Abstract
The P2X7 receptor, a plasma membrane ATP-gated ion channel that plays a role in lymphocyte apoptosis, has been suggested as an important contributory factor to the pathogenesis of chronic lymphocytic leukaemia (CLL). The P2X7 gene resides on chromosome 12 and is polymorphic in the population at large (1513A/C) with the A and C alleles encoding fully active and nonfunctional proteins, respectively. We have evaluated the significance of this polymorphism by genotyping 144 patients with CLL and 348 healthy controls using a tetraprimer ARMS assay. We found no significant difference in allele frequency between patients and controls. Although patients with the C allele (A/C heterozygotes or C/C homozygotes) had a marginally shorter survival than those who were homozygous for the A allele, this difference was not significant for either the patient group considered as a whole or for IgVH-mutated/unmutated subsets. Finally, no association was found between trisomy 12 and P2X7 genotype. We conclude that the influence, if any, of P2X7 genotype on susceptibility to CLL or clinical outcome is small.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Rozman C, Montserrat E . Chronic lymphocytic leukemia. N Engl J Med 1995; 333: 1052–1057.
Hamblin T . Chronic lymphocytic leukaemia: one disease or two? Ann Hematol 2002; 81: 299–303.
Wiley JS, Gargett CE, Zhang W, Snook MB, Jamieson GP . Partial agonists and antagonists reveal a second permeability state of human lymphocyte P2Z/P2X7 channel. Am J Physiol 1998; 275: C1224–1231.
Rassendren F, Buell GN, Virginio C, Collo G, North RA, Surprenant A . The permeabilizing ATP receptor, P2X7: cloning and expression of a human cDNA. J Biol Chem 1997; 272: 5482–5486.
Gu BJ, Zhang WY, Worthington RA, Sluyter R, Dao-Ung P, Petrou S et al. A Glu-496 to Ala polymorphism leads to loss of function of human the P2X7 receptor. J Biol Chem 2001; 276: 11135–11142.
Wiley JS, Dao-Ung LP, Gu BJ, Sluyter R, Shemon AN, Li CP et al. A loss-of-function polymorphic mutation in the cytolytic P2X7 receptor gene and chronic lymphocytic leukaemia: a molecular study. Lancet 2002; 359: 1114–1119.
Thunberg U, Tobin G, Johnson A, Soderberg O, Padyukov L, Hultdin M et al. Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukaemia. Lancet 2002; 360: 1935–1939.
Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK . Unmutated lgV(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood 1999; 94: 1848–1854.
Damle RN, Wasil T, Fais F, Ghiotto F, Valetto A, Allen SL et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood 1999; 94: 1840–1847.
Oscier DG, Gardiner AC, Mould SJ, Glide S, Davis ZA, Ibboston RE et al. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood 2002; 100: 1177–1184.
Adinolfi E, Melchiorri L, Falzoni S, Chiozzip P, Morelli A, Tieghi A et al. P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia. Blood 2002; 99: 706–708.
Brito-Babapulle V, Garcia-Marco J, Maljaie SH, Hiorns L, Coignet L, Conchon M et al. The impact of molecular cytogenetics on chronic lymphoid leukaemia. Acta Haematol 1997; 98: 175–186.
Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O'Brien S et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 1996; 87: 4990–4997.
Ye S, Dhillon S, Ke X, Collins AR, Day IN . An efficient procedure for genotyping single nucleotide polymorphisms. Nucleic Acids Res 2001; 29: E88–8.
Mattocks C, Tarpey P, Bobrow M, Whittaker J . Comparative sequence analysis (CSA): a new sequence-based method for the identification and characterization of mutations in DNA. Hum Mutat 2000; 16: 437–443.
Thunberg U, Tobin G, Johnson A, Enblad G, Rosenquist R . P2X7 polymorphism and chronic lymphocytic leukemia (letter). Lancet 2003; 361: 1478–1479.
Acknowledgements
This study was supported by the Wessex Cancer Trust and the China Scholarship Council. We thank Chris Mattocks for help with comparative sequence analysis.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Zhang, L., Ibbotson, R., Orchard, J. et al. P2X7 polymorphism and chronic lymphocytic leukaemia: lack of correlation with incidence, survival and abnormalities of chromosome 12. Leukemia 17, 2097–2100 (2003). https://doi.org/10.1038/sj.leu.2403125
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403125
Keywords
This article is cited by
-
Involvement of P2 receptors in hematopoiesis and hematopoietic disorders, and as pharmacological targets
Purinergic Signalling (2020)
-
Association between the rs3751143 polymorphism of P2RX7 gene and chronic lymphocytic leukemia: A meta-analysis
Purinergic Signalling (2020)
-
Molecular and functional properties of P2X receptors—recent progress and persisting challenges
Purinergic Signalling (2012)
-
P2 purinergic receptor modulation of cytokine production
Purinergic Signalling (2007)
-
P2X7 receptor: Death or life?
Purinergic Signalling (2005)